Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines

H Wada, T Matsumoto, Y Yamashita - Journal of Intensive Care, 2014 - Springer
Disseminated intravascular coagulation (DIC) is categorized into bleeding, organ failure,
massive bleeding, and non-symptomatic types according to the sum of vectors for …

Microparticles in cancer

J Rak - Seminars in thrombosis and hemostasis, 2010 - thieme-connect.com
Microparticles (MP) are vesicular structures released from cells upon activation, malignant
transformation, stress, or death. MP may be derived from the plasma membrane (shed …

[HTML][HTML] Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines

H Wada, J Thachil, M Di Nisio, P Mathew… - Journal of thrombosis …, 2013 - Elsevier
Disseminated intravascular coagulation (DIC) is a syndrome characterized by the systemic
activation of blood coagulation, which generates intravascular fibrin, leading to thrombosis …

[图书][B] Hayes' principles and methods of toxicology

AW Hayes, T Kobets - 2023 - taylorfrancis.com
Hayes' Principles and Methods of Toxicology has long been established as a reliable and
informative reference for the concepts, methodologies, and assessments integral to …

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710

BL Powell, B Moser, W Stock… - Blood, The Journal …, 2010 - ashpublications.org
Abstract Arsenic trioxide (As2O3) is a highly effective treatment for patients with relapsed
acute promyelocytic leukemia (APL); its role as consolidation treatment for patients in first …

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome …

P Montesinos, JM Bergua, E Vellenga… - Blood, The Journal …, 2009 - ashpublications.org
Differentiation syndrome (DS) can be a life-threatening complication in patients with acute
promyelocytic leukemia (APL) undergoing induction therapy with all-trans retinoic acid …

How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia

MA Sanz, P Montesinos - Blood, The Journal of the American …, 2014 - ashpublications.org
Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is a relatively
common and potentially severe complication seen in patients with acute promyelocytic …

[HTML][HTML] The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment

V De Stefano, F Sora, E Rossi, P Chiusolo… - Journal of Thrombosis …, 2005 - Elsevier
Background: Thromboembolism can occur during acute leukemia, especially acute
lymphoid leukemia (ALL) treated with l‐asparaginase. Yet, most reports are anecdotical and …

Venous thromboembolism in the hematologic malignancies

A Falanga, M Marchetti - Journal of Clinical Oncology, 2009 - ascopubs.org
Patients with hematologic malignancies are at high risk of thrombotic or hemorrhagic
complications. The incidence of these events is greatly variable and is influenced by many …

The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

KA Breen, D Grimwade, BJ Hunt - British journal of …, 2012 - Wiley Online Library
Coagulopathy occurs in most patients with (APML) and is life‐threatening; therefore prompt
diagnosis and recognition of any coagulation defect is imperative. Unfortunately …